Superior Planning, LLC’s AstraZeneca AZN Stock Holding History

Superior Planning, LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$117K	Buy	+723	New	+$120K	0.05%	222

Other funds holding AZN

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Aviva London, United Kingdom $70.5B AUM 31.52% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking Tokyo, Japan $47.2B AUM 26.24% 1-Year Est. Return

Superior Planning, LLC's AZN Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in AstraZeneca (AZN) in Q3 2026: 723 shares worth $117K. The stake represents 0.05% of the portfolio and ranks #222 among its holdings.

1,038 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Superior Planning, LLC held 723 shares of AstraZeneca worth $117K as of Q3 2026.
AstraZeneca was a new Superior Planning, LLC position in Q3 2026.
AstraZeneca made up 0.05% of Superior Planning, LLC's portfolio in Q3 2026, its #222 holding.
1,038 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.